Advisory board
CYLCOMED’s Advisory Board has four renowned experts from a variety of organisations and research institutions, all active players in related areas who have agreed to contribute their time. The AB offers support on state-of-the-art analyses as valuable inputs for EC policy impacts and future priorities and provides recommendations on the current European landscape.
Initial Advisory Board members are:
Antonio Kung
Co-founder, Trialog
Alessia Moltani
CEO of Comftech S.r.l
Stefano Finazzi
Laboratory of Clinical Data Science, Farmacological R. I. Mario Negri
